Literature DB >> 7166099

The Ocuplot semi-automatic visual field screener--technical evaluation and clinical results.

R W de Boer, T J van den Berg, E L Greve, L J de Heer, P Wiercx.   

Abstract

The perimetric concept and the technical construction of the Ocuplot were evaluated. The mechanical and electrical construction of the instrument we tested was poor. The manufacturer claims improvements in newer specimens. We examined 87 eyes of patients and normal subjects with the Ocuplot and learned that the test-strategy is not efficient and yields a high proportion of false positive results. Clinical results of the patient-examinations are presented.

Entities:  

Mesh:

Year:  1982        PMID: 7166099     DOI: 10.1007/bf00216793

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  3 in total

1.  Comparative evaluation of the Autofield-I, CFA-120, and Fieldmaster Model 101-PR automated perimeters.

Authors:  C A Johnson; J L Keltner
Journal:  Ophthalmology       Date:  1980-08       Impact factor: 12.079

2.  The competer automatic campimeter I. Technical description and evaluation.

Authors:  R W de Boer; T J van den Berg
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

3.  The fieldmaster 101 PR automatic visual field screener--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; E L Greve; H J Bos
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

  3 in total
  3 in total

1.  Concepts for automatic perimetry, as applied to the Scoperimeter, an experimental automatic perimeter.

Authors:  R W de Boer; T J van den Berg; E L Greve; B J de Waal
Journal:  Int Ophthalmol       Date:  1982-11       Impact factor: 2.031

2.  The competer automatic campimeter I. Technical description and evaluation.

Authors:  R W de Boer; T J van den Berg
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

3.  Performance of computer assisted perimeters.

Authors:  E L Greve
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.